Biblio Discovery — Demo Discovery Service

14 hasil untuk "Stuart Bloom"

Menampilkan 1–14 · 3,32 detik · RSS

  1. Artikel Jurnal

    Incidence and prevalence of inflammatory bowel disease in UK primary care: a population-based cohort study

    Nigel Field; Stuart Bloom; Greta Rait dkk.

    BMJ Open, Vol. 10 No. 7 · 2020 · Inggris · DOAJ Scopus

    Objectives We describe temporal trends in the recorded incidence of inflammatory bowel disease (IBD) in UK primary care patients between 2000 and 2018.Design A cohort study.Setting The IQVIA Medical Research data (IMRD) primary care database.Participants All individuals registered with general…

  2. Artikel Jurnal

    Prognostic biomarkers to identify patients likely to develop severe Crohn’s disease: a systematic review

    Steve Halligan; Darren Boone; Lucinda Archer dkk.

    Health Technology Assessment, Vol. 25 No. 45 · 2021 · Inggris · DOAJ Scopus

    Background: Identification of biomarkers that predict severe Crohn’s disease is an urgent unmet research need, but existing research is piecemeal and haphazard. Objective: To identify biomarkers that are potentially able to predict the development of subsequent severe Crohn’s disease. Design: This…

  3. Artikel Jurnal

    The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomes

    Keith Bodger; Cheryl Booker; Frederick Taylor dkk.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · Inggris · DOAJ Scopus

    Background: VEST was a multi-centre study of real-world use of vedolizumab in inflammatory bowel disease (IBD) in routine practice in the United Kingdom. Objectives: To describe real-world indications, effectiveness, patient-reported outcomes and safety. Design: Prospective observational cohort…

  4. Artikel Jurnal

    Real-world outcomes from the UK IBD Registry on second-line biologic therapy following anti-TNF exposure in Crohn’s disease: results from the BISCUITS study

    Frederick Taylor; Giorgio Bartalucci; Catherine Gleave dkk.

    Therapeutic Advances in Gastroenterology, Vol. 18 · 2025 · Inggris · DOAJ Scopus

    Background: Selection of second-line therapy in Crohn’s disease (CD) patients after failure of first-line TNFα-inhibitor (TNFi) therapy to optimise outcomes remains challenging in real-world clinical practice. Objectives: This study aimed to provide real-world outcomes of CD patients who failed…

  5. Artikel Jurnal

    METRIC-EF: magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn’s disease—protocol for a multicentre, non-randomised, single-arm, prospective study

    Ailsa L Hart; Gauraang Bhatnagar; Stuart Bloom dkk.

    BMJ Open, Vol. 12 No. 10 · 2022 · Inggris · DOAJ Scopus

    Introduction Crohn’s disease (CD) is characterised by discontinuous, relapsing enteric inflammation. Instituting advanced therapies at an early stage to suppress inflammation aims to prevent future complications such as stricturing or penetrating disease, and subsequent surgical resection…

  6. Artikel Jurnal

    MOTILITY: Small bowel motility quantified by cine MRI as a predictor of longer term response in patients with Crohn’s disease commencing biological therapy

    Andrew Plumb; Gordon Moran; Kashfia Chowdhury dkk.

    Efficacy and Mechanism Evaluation, Vol. 13 No. 02 · 2026 · Inggris · DOAJ

    Background Small bowel Crohn’s disease is increasingly treated with biological therapies. Although many patients do not achieve response or remission, this is unpredictable. Motility magnetic resonance imaging reliably measures Crohn’s disease inflammation, but its predictive ability for…

  7. Artikel Jurnal

    Two-year real-world outcome data from a single tertiary centre shows reduced ustekinumab persistence in a non-bio-naïve Crohn’s disease cohort with penetrating disease, -ostomies and sarcopenia

    Saskia Inniss; Konstantinos C. Fragkos; Lisa Whitley dkk.

    Therapeutic Advances in Chronic Disease, Vol. 14 · 2023 · Inggris · DOAJ Scopus

    Background: Ustekinumab was approved in 2016 for the treatment of moderate–severe Crohn’s disease (CD). Clinical trials and real-world studies have suggested ustekinumab to be a safe and effective treatment; however, studies to date infrequently use imaging techniques to predict response to…

  8. Artikel Jurnal

    Plasma extracellular vesicle proteomics nominates candidate biomarkers of 177Lu-PSMA-617 outcomes in metastatic prostate cancer patients

    Ali T. Arafa; Ella Boytim; Megan L. Ludwig dkk.

    Cell Reports Medicine, Vol. 7 No. 5 · 2026 · Inggris · DOAJ Scopus

    Summary: 177Lu-PSMA-617 represents a transformative treatment for metastatic castration-resistant prostate cancer (mCRPC), yet biomarkers of benefit beyond prostate-specific membrane antigen positron emission tomography (PSMA-PET) imaging remain lacking. Here, we present findings from a prospective…

  9. Artikel Jurnal

    Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn’s disease patients: the METRIC diagnostic accuracy study

    Stuart A Taylor; Sue Mallett; Gauraang Bhatnagar dkk.

    Health Technology Assessment, Vol. 23 No. 42 · 2019 · Inggris · DOAJ Scopus

    Background: Magnetic resonance enterography and enteric ultrasonography are used to image Crohn’s disease patients. Their diagnostic accuracy for presence, extent and activity of enteric Crohn’s disease was compared. Objective: To compare diagnostic accuracy, observer variability, acceptability…

  10. Artikel Jurnal

    Delphi consensus survey: the opinions of patients living with refractory ulcerative proctitis and the health care professionals who care for them

    Philip Smith; Stuart Bloom; Christian Selinger dkk.

    BMJ Open Gastroenterology, Vol. 10 No. 1 · 2023 · Inggris · DOAJ Scopus

    Background Refractory ulcerative proctitis presents a huge clinical challenge not only for the patients living with this chronic, progressive condition but also for the professionals who care for them. Currently, there is limited research and evidence-based guidance, resulting in many patients…

  11. Artikel Jurnal

    MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn’s disease

    Naomi S. Sakai; Andrew A. Plumb; Norin Ahmed dkk.

    Insights into Imaging, Vol. 16 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Objectives Altered body fat and muscle mass in Crohn’s disease (CD) have been linked to adverse disease course and outcomes. Prediction of treatment response or remission (RoR) of small bowel CD (SBCD) to biologic therapy remains challenging. We aimed to establish the prognostic value of…

  12. Artikel Jurnal

    Diagnostic accuracy of magnetic resonance enterography and intestinal ultrasound for treatment response assessment in Crohn’s disease (MANTRA): protocol for a multicentre, non-randomised, multiple-arm, prospective cohort comparison study

    Stuart Bloom; Steve Halligan; Stuart A Taylor dkk.

    BMJ Open, Vol. 16 No. 7 · 2026 · Inggris · DOAJ Scopus

    Introduction MR enterography (MRE) and intestinal ultrasound (IUS) are used to assess therapeutic response in Crohn’s disease (CD) follow-up. There is, however, no clear guidance regarding which modality should be used for individual patients or if they are interchangeable. Therefore, clinical…

  13. Artikel Jurnal

    Magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn’s disease: the METRIC-EF multivariable prediction model, multicentre diagnostic inception cohort study

    Shankar Kumar; Andrew Plumb; Sue Mallett dkk.

    Health Technology Assessment, Vol. 30 No. 18 · 2026 · Inggris · DOAJ Scopus

    …reproduced with permission from Kumar S, Plumb A, Mallett S, Bhatnagar G, Bloom S, Clarke CS, et al. METRIC-EF: magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn’s disease-protocol for a multicentre, non-randomised, single-arm, prospective study. BMJ Open…

  14. Artikel Jurnal

    Genome-Wide Methylation Profiling in 229 Patients With Crohn’s Disease Requiring Intestinal Resection: Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn’s Disease (TOPPIC)Summary

    Nicholas T. Ventham; Nicholas A. Kennedy; Rahul Kalla dkk.

    Cellular and Molecular Gastroenterology and Hepatology, Vol. 16 No. 3 · 2023 · Inggris · DOAJ Scopus

    Background & Aims: DNA methylation alterations may provide important insights into gene-environment interaction in cancer, aging, and complex diseases, such as inflammatory bowel disease (IBD). We aim first to determine whether the circulating DNA methylome in patients requiring surgery may predict…